万维提示:
1、该刊只有国际刊号。
2、投稿方式:在线投稿。
3、刊内网址:https://www.cardiologyplus.org/
4、投稿网址:
https://www.editorialmanager.com/cardioplus/default.aspx
5、主办单位网址:
https://www.ccahouse.org/Index/index.html
(中国心血管健康联盟)
6、官网邮箱:editor@cardiologyplus.org
7、官网电话:021-64041990(2745);13913504664
8、期刊刊期:季刊,一年出版4期。
9、微信公众号: 心血管健康联盟信息平台(ccahouse)
2021年10月26日星期二
《心血管病+(英文)》(Cardiology Plus)期刊简介
Cardiology Plus杂志作为中国心血管领域首个权威英文期刊,在2016年3月正式出版发行,由复旦大学附属中山医院、中国医师协会心血管分会会长、心血管健康联盟主席葛均波院士和北京大学第一医院、亚洲心脏学会主席、心血管健康联盟副主席霍勇教授等创办。同时,Cardiology Plus杂志是心血管健康联盟(Chinese Cardiovascular Association, CCA)的会刊,是心血管健康联盟最重要的国际化心血管疾病学术交流平台。
Cardiology Plus杂志目前为季度刊,是一本全英文综合性的心血管疾病和相关学科的专业学术期刊,涵盖了从基础医学研究到临床研究的心脏病学的所有方面,以从事心血管疾病预防、诊疗与科研的医务工作者为主要阅读对象。主要栏目有:述评、观点、综述、研究类文章、指南与共识、病例报告等。Cardiology Plus杂志编辑委员会由国内外著名心血管领域顶级专家组成,编委成员遍布全球,如Sidney C. Smith, Jr.(美国心脏协会AHA前任主席、世界心脏联合会WHF前任主席)、Fausto J. Pinto(世界心脏联合会WHF候任主席、欧洲心脏病学会主席ESC 2014-2016)、Roberto Ferrari(欧洲心脏病学会主席ESC 2008-2010)等。
《心血管病+(英文)》(Cardiology Plus)投稿须知
【官网信息】
Instructions to Authors
Editorial Process
A manuscript will be reviewed for possible publication with the understanding that the manuscript is the original work of the authors; does not duplicate any other previously published work of the authors, and has been submitted solely to Cardiology Plus and not simultaneously submitted elsewhere or under consideration or peer review, accepted for publication or published elsewhere. For publications with more than one author, the Journal expects authors to authorize one of them to correspond with the Journal on all matters related to the manuscript. Received manuscripts will be acknowledged. Initially, editors review all submitted manuscripts for suitability for formal peer-review. The journal follows single-blind peer-review process. Manuscripts that lack originality, have serious scientific or technical flaws, or are unlikely to be of interest to Cardiology Plus readers are rejected before proceeding to formal peer-review.
Manuscripts deemed suitable for formal peer-review are sent to two or more expert reviewers. During submission, authors may has an opportunity to identify two or three qualified reviewers with experience in the subject of the submitted manuscript but are not required to do so. Reviewers should not be affiliated with the same institution(s) as the author/s. Selection of reviewers is at the sole discretion of the editor. The Journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other's identity. Additionally, every manuscript is assigned to a member of the editorial team, who, based on comments from the reviewers, makes a final decision as to whether the manuscript shall be published. Reviewer comments and suggestions (acceptance/ rejection/ revisions or amendments to manuscript) are conveyed to the corresponding author. Authors may be required to provide a point-by-point response to reviewers' comments and submit a revised manuscript. This process is repeated until reviewers and editors are satisfied with the manuscript and deem it publishable in Cardiology Plus.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs will be provided to the corresponding author. The corresponding author is expected to return corrected proofs within fourteen days of their receipt by the author. Revisions may not be incorporated in the final publication if proofs are not returned in a timely fashion. The process of manuscript submission to final decision and sending and receiving of proofs is completed online. The Journal is committed to expedient dissemination of knowledge and information. As such, immediately upon acceptance, articles are published online as 'Ahead of Print'.
Clinical Trial Registry
Cardiology Plus only publishes clinical trials registered with a clinical trial registry that allows free online access to the public. Registration in the following trial registries is acceptable: http://www.ctri.nic.in/; https://www.anzctr.org.au/; http://www.clinicaltrials.gov/; http://isrctn.org/; http://www.trialregister.nl/trialreg/index.asp; and http://www.umin.ac.jp/ctr. This is applicable to clinical trials that started enrolling subjects as early as June 2008. To be considered for publication in Cardiology Plus, clinical trials that commenced subject enrollment prior to June 2008 must be registered retrospectively with a clinical trial registry that allows unhindered and free-of-charge online access to the public.
Authorship Criteria
Authorship credit should be based on substantial contributions to each of the following three components:
Concept and design of study or acquisition of data or analysis and interpretation of data;
Drafting of manuscript or revising of manuscript critically for important intellectual content; and
Final approval of manuscript to be published.
Participation solely in acquisition of funding or collection of data does not justify authorship. General supervision of the research group from which the manuscript originates is not sufficient for authorship. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the manuscript content. The order in which authors are listed should be based on the relative contribution of each author towards the study and writing of the manuscript. Once submitted, the order in which authors are listed cannot be changed without written consent of all authors. The Journal prescribes a maximum number of authors for manuscripts depending upon the type of manuscript, its scope, and the number of institutions involved (vide infra). Authors should provide a justification, if the number of authors exceeds the requisite limits.
Contribution Details
Each author shall describe his or her contributions with respect to the manuscript. Such description shall be divided into the following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. One or more authors shall assume responsibility for the integrity of the work as a whole from inception to published article and should be designated as corresponding author/s.
Conflicts of Interest/ Competing Interests
Each author must disclose any and all perceived or actual conflicts of interest that he or she (or his or her institution) may have related to publication of the manuscript. In particular if any of the authors have a financial interest related to products or processes that are mentioned in the manuscript, these conflicts of interest must be disclosed. If any of the authors have a financial interest in products or processes that are competitive with those mentioned in the manuscript, such financial interest must be disclosed.
Manuscripts received from Editorial Board members will be screened by the Editor in Chief and sent to external peer reviewers. The editorial board members who are authors will be excluded from publication decisions and need to acknowledge in the “Conflicts of interest” statement that they are Editorial Board members of the journal.
Submission of Manuscripts
ll manuscripts must be submitted online through the website Cardiology Plus Submission Portal. An author submitting a manuscript to the Journal for the first time, then you must register. Registration is free but mandatory. Registered authors can track submitted manuscripts by logging in.
The Journal does not charge for submission and processing of manuscripts.
If an author experiences any issues with manuscript submission, that author should contact the editorial office by sending an email to editor@cardiologyplus.org or call +86-13913504664.
……
更多详情:
https://www.cardiologyplus.org/contributors.asp